TSHA vs BHRB
Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.
TSHA · Taysha Gene Therapies$4.33 ▲ 5.87%
BHRB · Burke & Herbert Financial Services$69.88 ▲ 0.03%
One year, rebased to 100
Each line starts at 100 so growth is directly comparable
- TSHA +11.3%
- BHRB +18.0%
Head to head
| Metric | TSHA | BHRB |
|---|---|---|
| Price | $4.33 | $69.88 |
| Change today | ▲ 5.87% | ▲ 0.03% |
| Market cap | $1.41B | $1.41B |
| Return, 3 months | -32.0% | -3.2% |
| Return, year to date | -21.3% | +14.9% |
| Return, 1 year | +13.1% | +19.6% |
| P/E (TTM) | – | 11.6 |
| P/B | 3.6 | 1.2 |
| P/E percentile vs own 5y | 21st | 51st |
| Dividend yield | – | 3.15% |
| Revenue growth (YoY, latest qtr) | -100.0% | +40.1% |
| Net profit growth (YoY) | -73.5% | +21.4% |
| Gross margin | – | – |
| Operating margin | -2,854.9% | – |
| Net margin | -2,728.0% | 26.1% |
| Return on equity | -47.1% | 10.5% |
| Analyst target vs. price | +237.2% | +11.6% |
| Analyst buy share | 100% | 50% |
| RSI (14) | 51 | 48 |
| 30-day volatility | 76.5% | 21.5% |
| Max drawdown, 1 year | -49.7% | -13.1% |
| Trend read | Leaning bullish | Leaning bearish |
| Analyst consensus | Buy | Buy |
Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.
What the numbers say
- TSHA is the largest of the group by market value.
- BHRB has returned the most over the past year.
- BHRB is growing revenue fastest.
- BHRB keeps the most profit per dollar of sales.
- BHRB has been the calmest stock over the last 30 days.